Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205

Cited by (610)

Items 101–200 of 610

1. Pathological properties of the Parkinson?s disease-associated protein DJ-1 in a-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick?s disease
   Manuela Neumann, Veronika M�ller, Karin G�rner, Hans A. Kretzschmar, Christian Haass, Philipp J. Kahle · 2004 · Acta Neuropathologica
2. Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer’s disease
   Siddhartha Mondragón‐Rodríguez, Gustavo Basurto‐Islas, Ismael Santa‐María, Raúl Mena, Lester I. Binder, Jesús Ávila, Mark A. Smith, George L. Perry, Francisco García‐Sierra · 2008 · International Journal of Experimental Pathology
3. p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis
   Nogalska, Anna, Terracciano, Chiara, D’Agostino, Carla, King Engel, W., Askanas, Valerie · 2009 · Acta Neuropathologica
4. Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease
   Valérie Buée‐Scherrer, Patrick R. Hof, Luc Buée, Béatrice Leveugle, Patrick Vermersch, Daniel P. Perl, C. Warren Olanow, André Delacourte · 1996 · Acta Neuropathologica
5. JNK Plays a Key Role in Tau Hyperphosphorylation in Alzheimer's Disease Models
   Ploia, Cristina, Antoniou, Xanthi, Sclip, Alessandra, Grande, Valentina, Cardinetti, Daniele, Colombo, Alessio, Canu, Nadia, Benussi, Luisa, Ghidoni, Roberta, Forloni, Gianluigi et al. · 2011 · Journal of Alzheimer's Disease
6. The neuropathological profile of mild cognitive impairment (MCI): a systematic review
   Blossom C. M. Stephan, Sally Hunter, D Harris, David J. Llewellyn, Mario Siervo, Fiona E. Matthews, Carol Brayne · 2011 · Molecular Psychiatry
7. Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer’s disease from a ferroptosis perspective
   Paul J. Derry, Muralidhar L. Hegde, George R. Jackson, Rakez Kayed, James M. Tour, Ah-Lim Tsai, Thomas A. Kent · 2019 · Progress in Neurobiology
8. Transient increases in intracellular calcium result in prolonged site-selective increases in tau phosphorylation through a glycogen synthase kinase 3β-dependent pathway
   Hartigan, Judith A., Johnson, Gail V.W. · 1999 · Journal of Biological Chemistry
9. Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies
   Strang, Kevin H., Croft, Cara L., Sorrentino, Zachary A., Chakrabarty, Paramita, Golde, Todd E., Giasson, Benoit I. · 2018 · Journal of Biological Chemistry
10. Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation
    Sheng, Jin G., Jones, Richard A., Zhou, Xue Q., McGinness, John M., Van Eldik, Linda J., Mrak, Robert E., Griffin, W.Sue T. · 2001 · Neurochemistry International
11. Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia
    Emmanuel Planel, Alexis Bretteville, Li Liu, László Virág, Angela L. Du, Wai Haung Yu, Dennis W. Dickson, Robert A. Whittington, Karen Duff · 2009 · The FASEB Journal
12. Palmitic and stearic fatty acids induce Alzheimer-like hyperphosphorylation of tau in primary rat cortical neurons
    Sachin P. Patil, Christina Chan · 2005 · Neuroscience Letters
13. Comparison of the neurofibrillary pathology in Alzheimer’s disease and familial presenile dementia with tangles
    Spillantini, M. G., Crowther, R. A., Goedert, M. · 1996 · Acta Neuropathologica
14. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice
    Chalermpalanupap, Termpanit, Schroeder, Jason P., Rorabaugh, Jacki M., Liles, L. Cameron, Lah, James J., Levey, Allan I., Weinshenker, David · 2018 · The Journal of Neuroscience
15. Normal and Pathological Tau Proteins as Factors for Microtubule Assembly
    André Delacourte, Luc Buée · 1997 · International review of cytology
16. Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer’s disease
    Roberts, Malcolm, Sevastou, Ioanna, Imaizumi, Yoichi, Mistry, Kavita, Talma, Sonia, Dey, Madhurima, Gartlon, Jane, Ochiai, Hiroshi, Zhou, Zhi, Akasofu, Shigeru et al. · 2020 · Acta Neuropathologica Communications
17. Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice
    Leroy, Karelle, Bretteville, Alexis, Schindowski, Katharina, Gilissen, Emmanuel, Authelet, Michèle, De Decker, Robert, Yilmaz, Zehra, Buée, Luc, Brion, Jean-Pierre · 2007 · The American Journal of Pathology
18. E46K Human α-Synuclein Transgenic Mice Develop Lewy-like and Tau Pathology Associated with Age-dependent, Detrimental Motor Impairment
    Kristel L. Emmer, Elisa A. Waxman, Jason P. Covy, Benoit I. Giasson · 2011 · Journal of Biological Chemistry
19. Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transport
    Kanaan, Nicholas M., Morfini, Gerardo, Pigino, Gustavo, LaPointe, Nichole E., Andreadis, Athena, Song, Yuyu, Leitman, Ellen, Binder, Lester I., Brady, Scott T. · 2012 · Neurobiology of Aging
20. Retinal tau pathology in human glaucomas
    Neeru Gupta, Jessica Fong, Lee Cyn Ang, Yeni H. Yücel · 2008 · Canadian Journal of Ophthalmology
21. The evolution of Alzheimer's disease‐related cytoskeletal pathology in the human raphe nuclei
    U. Rüb, Kelly Del Tredici, Christian Schultz, Dietmar Rudolf Thal, Eva Braak, Heiko Braak · 2000 · Neuropathology and Applied Neurobiology
22. Evidence that phosphorylation of the microtubule-associated protein Tau by SAPK4/p38δ at Thr50 promotes microtubule assembly
    Feijoo, Carmen, Campbell, David G., Jakes, Ross, Goedert, Michel, Cuenda, Ana · 2005 · Journal of Cell Science
23. Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation
    Caroline Smet‐Nocca, Malgorzata Broncel, Jean‐Michel Wieruszeski, Caroline Tokarski, Xavier Hanoulle, Arnaud Leroy, Isabelle Landrieu, Christian H. Rolando, Guy M. Lippens, Christian P. R. Hackenberger · 2011 · Molecular BioSystems
24. Propofol Directly Increases Tau Phosphorylation
    Robert A. Whittington, László Virág, François Marcouiller, Marie-Amélie Papon, Noura B. El Khoury, Carl Julien, Françoise Morin, Charles W. Emala, Emmanuel Planel · 2011 · PLoS ONE
25. Pick's disease associated with the novel Tau gene mutation K369I
    Manuela Neumann, Walter Schulz‐Schaeffer, R. Anthony Crowther, Michael J. Smith, Maria Grazia Spillantini, Michel Goedert, Hans A. Kretzschmar · 2001 · Annals of Neurology
26. Cyclooxygenase‐1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease
    Sangho Choi, Saba Aïd, Luca Caracciolo, Sakura Minami, Takako Niikura, Yasuji Matsuoka, Raymond Scott Turner, Mark P. Mattson, Francesca Bosetti · 2012 · Journal of Neurochemistry
27. Aberrant Tau Phosphorylation by Glycogen Synthase Kinase-3β and JNK3 Induces Oligomeric Tau Fibrils in COS-7 Cells
    Shinji Sato, Yoshitaka Tatebayashi, Takumi Akagi, De-Hua Chui, Miyuki Murayama, Tomohiro Miyasaka, Emmanuel Planel, Kentaro Tanemura, Xiaoyan Sun, Tsutomu Hashikawa et al. · 2002 · Journal of Biological Chemistry
28. Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease.
    Mengqi Xia, Shixin Qin, Megan J. McNamara, Charles Reay Mackay, Bradley T. Hyman · 1997 · Europe PMC (PubMed Central)
29. Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia
    Kövari, E., Gold, G., Herrmann, F. R., Canuto, A., Hof, P. R., Bouras, C., Giannakopoulos, P. · 2007 · Neurology
30. Alzheimer’s disease: Ablating single master site abolishes tau hyperphosphorylation
    Stefanoska, Kristie, Gajwani, Mehul, Tan, Amanda R. P., Ahel, Holly I., Asih, Prita R., Volkerling, Alexander, Poljak, Anne, Ittner, Arne · 2022 · Science Advances
31. NO synthase 2 ( NOS2 ) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease
    Colton, C. A., Vitek, M. P., Wink, D. A., Xu, Q., Cantillana, V., Previti, M. L., Van Nostrand, W. E., Weinberg, J. B., Dawson, H. · 2006 · Proceedings of the National Academy of Sciences
32. Tau and α-Synuclein Pathology in Amygdala of Parkinsonism-Dementia Complex Patients of Guam
    Mark S. Forman, Marie Luise Schmidt, Sanjay S. Kasturi, Daniel P. Perl, Virginia M.‐Y. Lee, John Q. Trojanowski · 2002 · American Journal Of Pathology
33. Involvement of astroglial ceramide in palmitic acid‐induced Alzheimer‐like changes in primary neurons
    Sachin P. Patil, Joseph Melrose, Christina Chan · 2007 · European Journal of Neuroscience
34. Dual modification of Alzheimer’s disease PHF-tau protein by lysine methylation and ubiquitylation: a mass spectrometry approach
    Thomas, Stefani N., Funk, Kristen E., Wan, Yunhu, Liao, Zhongping, Davies, Peter, Kuret, Jeff, Yang, Austin J. · 2012 · Acta Neuropathologica
35. Smoking exacerbates amyloid pathology in a mouse model of Alzheimer’s disease
    Inés Moreno‐González, Lisbell D. Estrada, Elisabeth Sánchez‐Mejías, Claudio A. Soto · 2013 · Nature Communications
36. Starvation induces tau hyperphosphorylation in mouse brain: implications for Alzheimer's disease
    Masahiro Yanagisawa, Emmanuel Planel, Koichi Ishiguro, Shinobu C. Fujita · 1999 · FEBS Letters
37. Analysis of Tau Phosphorylation and Truncation in a Mouse Model of Human Tauopathy
    Patrice Delobel, Isabelle Lavenir, Graham Mathew Fraser, Esther Ingram, Max Holzer, Bernardino Francesco Ghetti, Maria Grazia Spillantini, R. Anthony Crowther, Michel Goedert · 2007 · American Journal Of Pathology
38. Dishevelled Regulates the Metabolism of Amyloid Precursor Protein via Protein Kinase C/Mitogen-Activated Protein Kinase and c-Jun Terminal Kinase
    Amritpal K. Mudher, Susan C. Chapman, Jill C. Richardson, Ayodeji A. Asuni, Graham Gibb, Claire C. Pollard, Richard Killick, Tasfia Ahmed Iqbal, Frances Lucy Raymond, Ian M. Varndell et al. · 2001 · Journal of Neuroscience
39. Analysis of gial acidic fibrillary protein in the human entorhinal cortex during aging and in Alzheimer's disease
    Raymonde Porchet, A. Probst, Constantin Bouras, Eduarda Dráberová, Pavel Dráber, Beat Michel Riederer · 2003 · PROTEOMICS
40. Accumulation of Filamentous Tau in the Cerebral Cortex of Human Tau R406W Transgenic Mice
    Ikeda, Masaki, Kawarai, Toshitaka, Kawarabayashi, Takeshi, Matsubara, Etsuro, Murakami, Tetsuro, Sasaki, Atsushi, Tomidokoro, Yasushi, Ikarashi, Yasushi, Kuribara, Hisashi, Ishiguro, Koichi et al. · 2005 · The American Journal of Pathology
41. β-Amyloid deposition and tau phosphorylation in clinically characterized aged cats
    Elizabeth Head, K. Moffat, Pritam Das, Floyd M. Sarsoza, Wayne W. Poon, Gary M Landsberg, Carl W. Cotman, M.P. Murphy · 2004 · Neurobiology of Aging
42. Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages
    Tharick Ali Pascoal, Andréa Lessa Benedet, Dana Tudorascu, Joseph Therriault, Sulantha Sanjeewa Mathotaarachchi, Mélissa Savard, Firoza Zubeida Lussier, Cécile Tissot, Mira Chamoun, Min Su Kang et al. · 2021 · Brain
43. NMR Analysis of a Tau Phosphorylation Pattern
    Isabelle Landrieu, Ludovic Lacosse, Arnaud Leroy, Jean‐Michel Wieruszeski, Xavier Trivelli, Alain Sillen, Nathalie Sibille, Harald Schwalbe, Krishna Saxena, Thomas Langer et al. · 2006 · Journal of the American Chemical Society
44. A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition
    James Y. Garbern, Manuela Neumann, John Q. Trojanowski, Virginia M.‐Y. Lee, Gerald L. Feldman, Joy W. Norris, Michael J. Friez, Charles E. Schwartz, Roger E. Stevenson, Anders A. F. Sima · 2010 · Brain
45. Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein
    Robert Porzig, David L. Singer, Ralf Hoffmann · 2007 · Biochemical and Biophysical Research Communications
46. Reduced repressive epigenetic marks, increased DNA damage and Alzheimer's disease hallmarks in the brain of humans and mice exposed to particulate urban air pollution
    Lilian Calderón‐Garcidueñas, Andrea Herrera-Soto, Nur Jury, Barbara A. Maher, Angélica González-Maciel, Rafael Reynoso-Robles, Pablo Ruiz-Rudolph, Brigitte van Zundert, Lorena Varela‐Nallar · 2020 · Environmental Research
47. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies
    Yuxing Xia, Stefan Prokop, Kimberly-Marie M. Gorion, Justin D. Kim, Zachary A. Sorrentino, Brach M. Bell, Alyssa N. Manaois, Paramita Chakrabarty, Peter Davies, Benoit I. Giasson · 2020 · Acta Neuropathologica Communications
48. nNOS Expression in Reactive Astrocytes Correlates with Increased Cell Death Related DNA Damage in the Hippocampus and Entorhinal Cortex in Alzheimer's Disease
    Goran Šimić, Paul John Lucassen, Željka Krsnik, Božo Krušlin, Ivica Kostović, Bengt G. Winblad, Nenad Bogdanović · 2000 · Experimental Neurology
49. Altered sleep and EEG power in the P301S Tau transgenic mouse model
    Jerrah K. Holth, Thomas E. Mahan, Grace O. Robinson, Andréia Silva da Rocha, David M. Holtzman · 2017 · Annals of Clinical and Translational Neurology
50. Tau Protein and the Neurofibrillary Pathology of Alzheimer's Disease
    Michel Goedert · 1996 · Annals of the New York Academy of Sciences
51. Argyrophilic grain disease: widespread hyperphosphorylation of tau protein in limbic neurons
    Markus Tolnay, Maria Grazia Spillantini, Michel Goedert, JURG ULRICH, Dominique Langui, A. Probst · 1997 · Acta Neuropathologica
52. Synphilin-1 is present in Lewy bodies in Parkinson's disease
    Koichi Wakabayashi, Simone Engelender, Makoto Yoshimoto, Shoji Tsuji, Christopher A. Ross, Hitoshi Takahashi · 2000 · Annals of Neurology
53. Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer's disease
    José Luna‐Muñoz, Francisco García‐Sierra, Viviana Falcón, Ivón Menéndez, Laura Chávez-Macías, Raúl Mena · 2005 · Journal of Alzheimer s Disease
54. Somatodendritic localization of phosphorylated tau in neonatal and adult rat cerebral cortex
    Ken Tashiro, Masato Hasegawa, Yasuo Ihara, Takeshi Iwatsubo · 1997 · Neuroreport
55. Apoptosis-Related Protein Expression in the Hippocampus in Alzheimer’s Disease
    Zsuzsanna Nagy, Margaret M. Esiri · 1997 · Neurobiology of Aging
56. A novel tau‐based rhesus monkey model of Alzheimer's pathogenesis
    Danielle Beckman, Paramita Chakrabarty, Sean P. Ott, Amanda Dao, Eric Zhou, William G.M. Janssen, Kristine Donis‐Cox, Scott Muller, Jeffrey H. Kordower, John H. Morrison · 2021 · Alzheimer s & Dementia
57. Mitotic-like Tau Phosphorylation by p25-Cdk5 Kinase Complex
    Malika Hamdane, Anne‐Véronique Sambo, Patrice Delobel, Séverine Bégard, Anne Violleau, André Delacourte, Philippe Bertrand, Jesús Bénavidès, Luc Buée · 2003 · Journal of Biological Chemistry
58. Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo
    DeVos, Sarah L, Corjuc, Bianca T, Commins, Caitlin, Dujardin, Simon, Bannon, Riley N, Corjuc, Diana, Moore, Benjamin D, Bennett, Rachel E, Jorfi, Mehdi, Gonzales, Jose A et al. · 2018 · Brain
59. Staging of Alzheimer's Pathology in Triple Transgenic Mice: A Light and Electron Microscopic Analysis
    Oh, Kwang-Jin, Perez, Sylvia E., Lagalwar, Sarita, Vana, Laurel, Binder, Lester, Mufson, Elliott J. · 2010 · International Journal of Alzheimer's Disease
60. Alzheimer disease specific phosphoepitopes of Tau interfere with assembly of tubulin but not binding to microtubules
    Amniai, Laziza, Barbier, Pascale, Sillen, Alain, Wieruszeski, Jean-Michel, Peyrot, Vincent, Lippens, Guy, Landrieu, Isabelle · 2009 · The FASEB Journal
61. Early neurovascular dysfunction in a transgenic rat model of Alzheimer’s disease
    Illsung L. Joo, Aaron Y. Lai, Paolo Bazzigaluppi, Margaret M. Koletar, Adrienne E. Dorr, Mary E. Brown, Lynsie A.M. Thomason, John G. Sled, JoAnne McLaurin, Bojana Stefanovic · 2017 · Scientific Reports
62. Human iPSC-derived neuronal model of Tau-A152T frontotemporal dementia reveals tau-mediated mechanisms of neuronal vulnerability
    Silva, M. Catarina, Cheng, Chialin, Mair, Waltraud, Almeida, Sandra, Fong, Helen, Biswas, M. Helal U., Zhang, Zhijun, Huang, Yadong, Temple, Sally, Coppola, Giovanni et al. · 2016 · Stem Cell Reports
63. Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology.
    Leroy, Karelle, Ando, Kunie, Héraud, Céline, Yilmaz, Zehra, Authelet, Michèle, Boeynaems, Jean-Marie, Buée, Luc, De Decker, Robert, Brion, Jean-Pierre · 2010 · Journal of Alzheimer's Disease
64. Early‐stage attenuation of phase‐amplitude coupling in the hippocampus and medial prefrontal cortex in a transgenic rat model of Alzheimer's disease
    Paolo Bazzigaluppi, Tina L. Beckett, Margaret M. Koletar, Aaron Y. Lai, Illsung L. Joo, Mary E. Brown, Peter Louis Carlen, JoAnne McLaurin, Bojana Stefanovic · 2017 · Journal of Neurochemistry
65. Intraneuronal APP, Not Free Aβ Peptides In 3xTg-AD Mice: Implications For Tau Versus Aβ Mediated Alzheimer Neurodegeneration
    M. J. Winton, Edward B. Lee, Eveline Sun, Margaret M. Wong, S. Leight, Bin Zhang, J. Trojanowski, V. Lee · 2011 · Journal of Neuroscience · Retracted
66. Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer’s Disease
    Qiyue Ding, Nataliia V. Shults, Sergiy G. Gychka, Brent T. Harris, Yuichiro Suzuki · 2021 · International Journal of Molecular Sciences
67. Changes in the detergent‐insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression
    Hales, Chadwick M., Dammer, Eric B., Deng, Qiudong, Duong, Duc M., Gearing, Marla, Troncoso, Juan C., Thambisetty, Madhav, Lah, James J., Shulman, Joshua M., Levey, Allan I. et al. · 2016 · PROTEOMICS
68. Filamentous Tau Pathology in Nerve Cells, Astrocytes, and Oligodendrocytes of Aged Baboons
    Christian Schultz, Faramarz Dehghani, Gene B. Hubbard, Dietmar Rudolf Thal, Gernot Struckhoff, Eva Braak, Heiko Braak · 2000 · Journal of Neuropathology & Experimental Neurology
69. Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3β transgenes
    Janet Brownlees, Nicholas G. Irving, Jean‐Pierre Brion, Barry J. M. Gibb, Uta Wagner, James Robert Woodgett, Christopher C.J. Miller · 1997 · Neuroreport
70. Toxoplasma gondii alters NMDAR signaling and induces signs of Alzheimer’s disease in wild-type, C57BL/6 mice
    Luisa Torres, Sudie-Ann Robinson, Do-Geun Kim, Angela Yan, Thomas A. Cleland, Margaret S. Bynoe · 2018 · Journal of Neuroinflammation
71. Human misfolded truncated tau protein promotes activation of microglia and leukocyte infiltration in the transgenic rat model of tauopathy
    Norbert Žilka, Zuzana Stožická, Andrej Kováč, Emil Pilipcinec, Ondrej Bugos, Michal Novák · 2009 · Journal of Neuroimmunology
72. The autonomic higher order processing nuclei of the lower brain stem are among the early targets of the Alzheimer's disease-related cytoskeletal pathology
    Udo Rüb, Kelly Del Tredici, Christian Schultz, Dietmar Rudolf Thal, Eva Braak, Heiko Braak · 2001 · Acta Neuropathologica
73. Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease
    Giovannina Botez, A. Probst, Sabine Ipsen, Markus Tolnay · 1999 · Acta Neuropathologica
74. Transglutaminase bonds in neurofibrillary tangles and paired helical filament tau early in Alzheimer's disease
    Steven M Singer, Gina M. Zainelli, Maryam A. Norlund, John Michael Lee, Nancy A. Muma · 2002 · Neurochemistry International
75. Alzheimer's disease pathology in the neocortex and hippocampus of the western lowland gorilla (Gorilla gorilla gorilla)
    Perez, Sylvia E., Raghanti, Mary Ann, Hof, Patrick R., Kramer, Lynn, Ikonomovic, Milos D., Lacor, Pascale N., Erwin, Joseph M., Sherwood, Chet C., Mufson, Elliott J. · 2013 · Journal of Comparative Neurology
76. Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation
    Woo Shik Shin, Jing Di, Qin Cao, Binsen Li, Paul M. Seidler, Kevin A. Murray, Gal Bitan, Lin Jiang · 2019 · Alzheimer s Research & Therapy
77. Human iPSC-Derived Hippocampal Spheroids: An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies
    Pomeshchik, Yuriy, Klementieva, Oxana, Gil, Jeovanis, Martinsson, Isak, Hansen, Marita Grønning, de Vries, Tessa, Sancho-Balsells, Anna, Russ, Kaspar, Savchenko, Ekaterina, Collin, Anna et al. · 2020 · Stem Cell Reports
78. The Effects of NOS2 Gene Deletion on Mice Expressing Mutated Human AβPP
    Carol A. Colton, Donna M. Wilcock, David A. Wink, Judianne Davis, William E. Van Nostrand, Michael Peter Vitek · 2008 · Journal of Alzheimer s Disease
79. Amyloid Reduction by Amyloid- Vaccination Also Reduces Mouse Tau Pathology and Protects from Neuron Loss in Two Mouse Models of Alzheimer's Disease
    Donna M. Wilcock, Nastaran Gharkholonarehe, William E. Van Nostrand, J. Davis, Michael Peter Vitek, Carol A. Colton · 2009 · Journal of Neuroscience
80. Pseudo-phosphorylation of tau at Ser202 and Thr205 affects tau filament formation
    Rankin, Carolyn A., Sun, Qian, Gamblin, T. Chris · 2005 · Molecular Brain Research
81. Prolonged running, not fluoxetine treatment, increases neurogenesis, but does not alter neuropathology, in the 3xTg mouse model of Alzheimer’s disease
    Marlatt, Michael W., Potter, Michelle C., Bayer, Thomas A., van Praag, Henriette, Lucassen, Paul J. · 2013 · Current Topics in Behavioral Neurosciences
82. p73 Regulates Neurodegeneration and Phospho-Tau Accumulation during Aging and Alzheimer's Disease
    Monica K. Wetzel, Sibel Naska, Christine L. Laliberté, Vladimir V. Rymar, Masashi Fujitani, Jeffrey Biernaskie, Christy J. Cole, Jason P. Lerch, Shoshana Spring, Szu‐Han Wang et al. · 2008 · Neuron
83. Differential impact of lacunes and microvascular lesions on poststroke depression
    Santos, Micaela, Gold, Gabriel, Kövari, Enikö, Herrmann, Francois R., Bozikas, Vasilis P., Bouras, Constantin, Giannakopoulos, Panteleimon · 2009 · Stroke
84. Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease
    Maryam A. Norlund, John Michael Lee, Gina M. Zainelli, Nancy A. Muma · 1999 · Brain Research
85. High prevalence of thorn-shaped astrocytes in the aged human medial temporal lobe
    Christian Schultz, Estifanos Ghebremedhin, Kelly Del Tredici, Udo Rüb, Heiko Braak · 2003 · Neurobiology of Aging
86. Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms
    Tolnay, Markus, Sergeant, Nicolas, Ghestem, Antoine, Chalbot, Sonia, de Vos, Rob A., Jansen Steur, Ernst N., Probst, Alphonse, Delacourte, André · 2002 · Acta Neuropathologica
87. Presence of Reactive Microglia and Neuroinflammatory Mediators in a Case of Frontotemporal Dementia with P301S Mutation
    Arianna Bellucci, Orso Bugiani, Bernardino Francesco Ghetti, Maria Grazia Spillantini · 2011 · Neurodegenerative Diseases
88. Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1
    Allal Boutajangout, Michèle Authelet, Véronique Blanchard, Nathalie Touchet, Günter L. Tremp, Laurent Pradier, Jean‐Pierre Brion · 2003 · Neurobiology of Disease
89. Phosphorylation of Tau, Aβ-Formation, and Apoptosis After In Vivo Inhibition of PP-1 and PP-2A
    Thomas Arendt, Max Holzer, R. Fruth, Martina K. Brückner, Ulrich Gärtner · 1998 · Neurobiology of Aging
90. Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies
    Jens Wagner, Sybille Krauß, Song Shi, Sergey Ryazanov, Julia Steffen, Carolin Miklitz, Andrei Leonov, Alexander Kleinknecht, Bettina Göricke, Jochen Hans Weishaupt et al. · 2015 · Acta Neuropathologica
91. The AAA+ chaperone VCP disaggregates Tau fibrils and generates aggregate seeds in a cellular system
    Itika Saha, Patricia Yuste‐Checa, Miguel da Silva Padilha, Qiang Guo, Roman Körner, Hauke Holthusen, Victoria A. Trinkaus, Irina Dudanova, Rubén Fernández‐Busnadiego, Wolfgang P. Baumeister et al. · 2023 · Nature Communications
92. Protein restriction cycles reduce IGF ‐1 and phosphorylated Tau, and improve behavioral performance in an Alzheimer's disease mouse model
    Edoardo Parrella, Tom Maxim, Francesca Maialetti, Lu Zhang, Junxiang Wan, Min Wei, Pinchas Cohen, Luigi Fontana, Valter Daniel Longo · 2013 · Aging Cell
93. Using Human iPSC-Derived Neurons to Model TAU Aggregation
    Verheyen, An, Diels, Annick, Dijkmans, Joyce, Oyelami, Tutu, Meneghello, Giulia, Mertens, Liesbeth, Versweyveld, Sofie, Borgers, Marianne, Buist, Arjan, Peeters, Pieter et al. · 2015 · PLOS ONE
94. Amyloid‐β‐induced toxicity of primary neurons is dependent upon differentiation‐associated increases in tau and cyclin‐dependent kinase 5 expression
    Tianbing Liu, George L. Perry, Hsien W. Chan, Giuseppe Verdile, Ralph Nigel Martins, Mark A. Smith, Craig Atwood · 2003 · Journal of Neurochemistry
95. Pathological conformations involving the amino terminus of tau occur early in Alzheimer's disease and are differentially detected by monoclonal antibodies
    Benjamin Combs, Chelsey Hamel, Nicholas M. Kanaan · 2016 · Neurobiology of Disease
96. Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus
    Max Holzer, Ulrich Gärtner, Andrea Stöbe, Wolfgang Härtig, Hildegard Gruschka, Martina K. Brückner, Thomas Arendt · 2002 · Acta Neuropathologica
97. Phosphorylation of tau by glycogen synthase kinase 3β affects the ability of tau to promote microtubule self-assembly
    Michelle A. Utton, André Vandecandelaere, Uta Wagner, C. Hugh Reynolds, Graham Gibb, Christopher C.J. Miller, Peter M. Bayley, Brian H. Anderton · 1997 · Biochemical Journal
98. Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Aβ42 immunisation in Alzheimer’s disease
    Boche, Delphine, Donald, Jane, Love, Seth, Harris, Scott, Neal, James W., Holmes, Clive, Nicoll, James A. R. · 2010 · Acta Neuropathologica
99. Characterization of a double (amyloid precursor protein-tau) transgenic: Tau phosphorylation and aggregation
    Mar Pérez, Elena M. Ribé, Alicia Rubio, Filip Lim, M.A. Morán, Pilar Gómez‐Ramos, Isidró Ferrer, M.T.G. Isla, Jesús Ávila · 2004 · Neuroscience
100. Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease
     Nigel J. Cairns, Penny F Atkinson, Diane P. Hanger, Brian H. Anderton, S. E. Daniel, Peter L Lantos · 1997 · Neuroscience Letters